Inhibition of C-Met Is a Potential Therapeutic Strategy for Treatment of Diffuse Large B-Cell Lymphoma

Laboratory Investigation - United Kingdom
doi 10.1038/labinvest.2010.108
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Inhibition of Fatty Acid Synthase Suppresses C-Met Receptor Kinase and Induces Apoptosis in Diffuse Large B Cell Lymphoma.

Blood
BiochemistryImmunologyCell BiologyHematology
2009English

Diffuse Large B-Cell Lymphoma

2020English

Is Radiotherapy Still Necessary for Diffuse Large B-Cell Lymphoma Therapy?

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2015English

Overexpression of FoxM1 Offers a Promising Therapeutic Target in Diffuse Large B-Cell Lymphoma

Haematologica
Hematology
2012English

Diffuse Large B-Cell Lymphoma: A Case Report

Clinical and Experimental Health Sciences
2018English

Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma

Seminars in Diagnostic Pathology
Forensic MedicinePathology
2011English

KLHL6 Is a Tumor Suppressor Gene in Diffuse Large B-Cell Lymphoma

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2019English

ALK -Positive Diffuse Large B-Cell Lymphoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Treatment Pathways of Diffuse Large B-Cell Lymphoma in German Claims Data

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy